- Joined
- Sep 7, 2014
- Messages
- 3,489
- Reaction score
- 6,430
So what's the deal with masks? Nobody asked me to wear one. Shouldn't they be called mtells?
Your examples are mostly immaterial. Would you expect a Republican president to cut military spending and piss off his base?
The clutching of pearls from those in academia in having a President target for cuts the group of the population that has been nearly 100% against him from Day 1 is what I don't think I'm understanding. To reiterate, I don't agree with the move (as done), but did we expect this president to not have academic institutions in his crosshairs?
As an unbiased observer, how many people have their hand in the cookie jar that is academia that aren't adding (sufficient) value?
If an institution sees the indirect cuts and wants to lay off its people who have direct grant funding... then I don't know what to say to that. Don't do that?
In regards to increasing payline - If, pre-rule, let's say the NIH budget is 100M and say each investigator gets 1M but their university gets 0.6M (60% indirect cost), that means 62.5 investigators can be funded.
Post-rule, say each investigator still gets 1M but their university gets 0.15M (15% indirect cost), that means 86.9 investigators can be funded.
MOD NOTE - This thread is walking a tightrope of stuff that's worthy of talking about but breaking of SDN's no political discussion rule out of SPF. I'm guilty of it as well, but let's try to ensure that the discussion is in regards to NIH funding cuts and its influence and not go too broadly into a discussion about politics. Leaving the stuff about debt and naval superiority for the time being but if we get even more tangential I may have to prune the thread and put it on a path to being locked.
It doesn't surprise me that Trump cut NIH funding... he's cutting everything that won't make him or his buddies moneyYour examples are mostly immaterial. Would you expect a Republican president to cut military spending and piss off his base?
The clutching of pearls from those in academia in having a President target for cuts the group of the population that has been nearly 100% against him from Day 1 is what I don't think I'm understanding. To reiterate, I don't agree with the move (as done), but did we expect this president to not have academic institutions in his crosshairs?
As an unbiased observer, how many people have their hand in the cookie jar that is academia that aren't adding (sufficient) value?
If an institution sees the indirect cuts and wants to lay off its people who have direct grant funding... then I don't know what to say to that. Don't do that?
In regards to increasing payline - If, pre-rule, let's say the NIH budget is 100M and say each investigator gets 1M but their university gets 0.6M (60% indirect cost), that means 62.5 investigators can be funded.
Post-rule, say each investigator still gets 1M but their university gets 0.15M (15% indirect cost), that means 86.9 investigators can be funded.
MOD NOTE - This thread is walking a tightrope of stuff that's worthy of talking about but breaking of SDN's no political discussion rule out of SPF. I'm guilty of it as well, but let's try to ensure that the discussion is in regards to NIH funding cuts and its influence and not go too broadly into a discussion about politics. Leaving the stuff about debt and naval superiority for the time being but if we get even more tangential I may have to prune the thread and put it on a path to being locked.
Yeah, as someone in community cancer care, it's tempting to crap on academia, and I have of course questioned the pricing of academic medicine, the corporate culture of academia, the negative aspects of academic careerism, the cost of consolidation under academic umbrellas and things like the proton boondoggle over the years.just a bit of schattenfreude -never a great look.
Honestly, it is a little disappointing to see a bunch of folks here taking the side of a bully over their colleagues'.
PP vs academicia acrimony is next level in the specialty of radiation oncology in a way I've never seen in any other specialty. And it's sadly deserved IMHOIt doesn't surprise me that Trump cut NIH funding... he's cutting everything that won't make him or his buddies money
What surprised (if only a little bit) was how many folks here are willing to carry his water on that decision. Would hope that the PP vs. Academia thing here was like a sibling rivalry... sure it can get nasty, but no one should tolerate someone outside the family attacking their brother or sister.
...when the current administration is proposing cutting cancer research funding by 12.5% ($4 billion off a $32 Billion), we have a bunch of cancer doctors saying "well, I guess those greedy academics will have to be more efficient".
Honestly, it is a little disappointing to see a bunch of folks here taking the side of a bully over their colleagues'. Given the lack concern for genuine wasteful government spending elsewhere in the budget, I have to imagine the only reason for the dog piling on cancer research by posters here is just a bit of schattenfreude -never a great look.
Would hope that the PP vs. Academia thing here was like a sibling rivalry... sure it can get nasty, but no one should tolerate someone outside the family attacking their brother or sister.
Literally just posted the same thing before you. JinxYou seem like a great guy and professor and you could easily be one of the nicest and most accomplished mentors I had in training if I had to guess identities. I don’t have a good answer for your kindness and generosity. It just seems like the powerful people in rad onc, and let’s face it that equals powerful rad onc chairs mostly, don’t care that much about trainees or the specialty as a whole, at least over the last decade I’ve been in rad onc. I don’t know, maybe the wrong people got promoted way back when.
PP vs academicia acrimony is next level in the specialty of radiation oncology in a way I've never seen in any other specialty. And it's sadly deserved IMHO
This has been discussed ad nauseam. Big vs little rad onc Simuls monologue, chirag shahs 2013 "bloodbath" editorial in red journal etcWould be lying if I said I understood it completely, as I am sure I have lucked out in my personal interactions -got smacked around in residency in a traditionally "tough" program, but nothing that left a permanent mark. These days, for the most part, I am lucky enough to get to do my own thing at a mothership, and do enough research/see enough patients that no one bugs me too much. As for PP, my only interactions have been positive
...from reading comments here, I get the sense that there are some deep, personal wounds that go beyond the superficial silliness of the verbose academic twitteratti.
Would just remind the other posters here that most of us in academics are not your former chairs, the ones who scooped your research, or the ones who blamed all of the residents for a bad physics board exam -just nameless, faceless grunts like me, trying to see patients and run a few clinical trials here and there.
This has been discussed as nauseam. Big vs little rad onc Simuls monologue, chirag shahs 2013 "bloodbath" editorial in red journal etc
PP didn't expand residencies or engage in hypocritical "choosing wisely " campaigns or make ridiculous direct supervision arguments to CMS, or try to prevent physician ownership of linacs through the Astro pac etc
I'm sure you're aware of all of this. I just haven't seen this kind of thing between academia and PP in other specialties
Honestly, Im surprised that it took so many days for someone to make the academic versus community accusation 🤣
Certainly not re-litigating... and I am well aware that I have been spared the worst of academics and that many in PP were directly hurt by academic policies. Would just reiterate that point made much more eloquently by @communitydoc13: de-prioritizing cancer research does not bode well for either side of the divide.This has been discussed as nauseam. Big vs little rad onc Simuls monologue, chirag shahs 2013 "bloodbath" editorial in red journal etc
PP didn't expand residencies or engage in hypocritical "choosing wisely " campaigns or make ridiculous direct supervision arguments to CMS, or try to prevent physician ownership of linacs through the Astro pac etc
I'm sure you're aware of all of this. I just haven't seen this kind of thing between academia and PP in other specialties
I am sure you just place a high value on fiscal responsibility, and have a specific passion for assuring that cancer research -above all other forms of spending- is conducted with the utmost efficiency. Better a discovery missed than a dollar wasted, right NMS? Perhaps Musk can use your help!🤣
lol, common buddy. This isn't just you having an ax to grind? You can admit it
Unfortunately, many people who are willing to endure the incessant nonsense of leadership are those least morally equipped to wield its power… this isn’t unique to rad onc, but we are heavily afflicted.You seem like a great guy and professor and you could easily be one of the nicest and most accomplished mentors I had in training if I had to guess identity. I don’t have a good answer for your kindness and generosity. It just seems like the powerful people in rad onc, and let’s face it that equals powerful rad onc chairs mostly, don’t care that much about trainees or the specialty as a whole, at least over the last decade I’ve been in rad onc. I don’t know, maybe the wrong people got promoted way back when. Maybe it’s wrong to cast blame across all academics when it’s a small inner circle making most decisions, but I also don’t want every city’s cancer care to be dominated by an MDA satellite and for every PGY5 graduate to have to kowtow to a small number of decision makers to live in a decent city.
Glad I can count you as a noble colleague 🙂If I have to pick between being a noble academic trying to cure cancer or an angry community practitioner with an axe to grind, I guessssss I pick the former. I hope Im not making a mistake.
It doesn't surprise me that Trump cut NIH funding... he's cutting everything that won't make him or his buddies money
What surprised (if only a little bit) was how many folks here are willing to carry his water on that decision. Would hope that the PP vs. Academia thing here was like a sibling rivalry... sure it can get nasty, but no one should tolerate someone outside the family attacking their brother or sister.
...when the current administration is proposing cutting cancer research funding by 12.5% ($4 billion off a $32 Billion), we have a bunch of cancer doctors saying "well, I guess those greedy academics will have to be more efficient".
Honestly, it is a little disappointing to see a bunch of folks here taking the side of a bully over their colleagues'. Given the lack concern for genuine wasteful government spending elsewhere in the budget, I have to imagine the only reason for the dog piling on cancer research by posters here is just a bit of schattenfreude -never a great look.
Hesitant to reply as this seems so obviously trollish.rate of fraud/non-reproducibility of biomedical research seems to match the administrative overhead >60%
Too much to address briefly but one thing worth mentioning is journal policies play a huge role in addressing non-reproducibility. Pre-clinical cancer models are inherently unstable. You can't and shouldn't do something once in a single model and publish the results. Most quality journals now require showing something novel in 3-5 lines in vitro and 2+ in vivo to publish.Hesitant to reply as this seems so obviously trollish.
There is no evidence that I am aware of that NIH funded researchers or researchers at large institutions or academic researchers in general are more prone to bad science than any other group of scientists.
Excellent article above. I even suspect that our esteemed academics on this board would probably agree that a couple (1-3) quality publications a year (particularly if doing hard stuff like basic or translational work) is more in line with what a really bright and conscientious scientist should be aiming for than the insane productivity numbers that have become standard in some fields...again, not relatable to NIH infrastructure funding.
Pressure to publish, secondary gain and conflicts of interest all seem to influence scientists. Pressure to publish is probably the biggest culprit regarding fraudulent and poor-quality publication IMO. I don't see any of this being relatable to NIH infrastructure funding. Of course, industry scientists (who have done fabulous work over the years) are often associated with blatant cover-ups and sequestration of important data for public health when it is incompatible with corporate goals.
Maybe securely employed federal scientists with limited opportunity to cash in on intellectual property, reduced pressure to publish and very low COI are the best practitioners of science, or at least the most reliable?
![]()
I'm sorry that you feel so personally attacked by others on this forum that we can't even have a discussion about this topic without it offending your sensibilities.
AI is coming hard for these types of human misbehavior, AI's current version is actually a great fit to weed out publishing fraudHesitant to reply as this seems so obviously trollish.
There is no evidence that I am aware of that NIH funded researchers or researchers at large institutions or academic researchers in general are more prone to bad science than any other group of scientists.
Excellent article above. I even suspect that our esteemed academics on this board would probably agree that a couple (1-3) quality publications a year (particularly if doing hard stuff like basic or translational work) is more in line with what a really bright and conscientious scientist should be aiming for than the insane productivity numbers that have become standard in some fields...again, not relatable to NIH infrastructure funding.
Pressure to publish, secondary gain and conflicts of interest all seem to influence scientists. Pressure to publish is probably the biggest culprit regarding fraudulent and poor-quality publication IMO. I don't see any of this being relatable to NIH infrastructure funding. Of course, industry scientists (who have done fabulous work over the years) are often associated with blatant cover-ups and sequestration of important data for public health when it is incompatible with corporate goals.
Maybe securely employed federal scientists with limited opportunity to cash in on intellectual property, reduced pressure to publish and very low COI are the best practitioners of science, or at least the most reliable?
Nothing says intelligence like blanket cuts at large entities by managers who have yet to understand what they do.
The new administration in a few days is aware of all USAID or NIH does to the point they are comfortable drastically reducing expenditures and staff? And this is being defended, through the microcosm of the overhead system?
The NIH cuts will significantly impact research funding, staffing, cancer center budgets, research, and academic employment at levels far beyond but still directly impacting our field. It’s not a good change for patients, science, or us.
A cut to facilites and administration fees (aka "overhead") is functionally a cut to research - those costs - particularly the facilites will be passed onto the "direct" budget - thus our $ won't go as far and for any given grant we will be able to do less work.it is my understanding that there is a cap on overhead% not cuts to the grants. Maybe 15% is too low, but the system is in need of reform. Universities have become hedge funds w/nonsensical endowments. Cambrigdge and Oxford have endowments of around 2 bill vs 50 for Harvard.
A cut to facilites and administration fees (aka "overhead") is functionally a cut to research - those costs - particularly the facilites will be passed onto the "direct" budget - thus our $ won't go as far and for any given grant we will be able to do less work.
I think it is worth noting that the "standard" NIH grant amount for an R01 (the majority of grants) hasn't changed in 25 years (250K/yr). You can request more, but only up to 500K/yr. Meanwhile we have tried our best to keep salaries of research staff increasing at the rate of inflation. It's not hard to see this leaves less $ for everything else... In our group, i estimate costs of supplies has nearly doubled in the last 7 years. Those are not going down.
Regarding endowments - universities are often limited in how they can spend these funds. They can't be drawn down, they often can't be used for facilities. Major donors often have the right to recoup their donation if it is no longer being directed in the way they intended. so while the amounts seem huge, and at many places they are, the ability to use these to pay for F&A is somewhat limited.
I'm all for supporting research, but the fact we are supposed to allow the universities to say "we have a ton of money in our endowment but can't spend it" is complete nonsense. Rules about endowments weren't etched in stone via lightning from The Heavens.
Easy answer: set significance levels to 0.005 instead of 0.05, and reproducibility would go up… significantly.I don't agree with Ricky or Prasad all of the time. But let's talk about this stuff. The rate of non-reproducibility is way too high. Hiding data points can make the difference between a big thumbs up or not. The rates of fraud are way too high, bar none, for everyone. A lot of countries have issues with research, not just the US. Even if it's not just complete "fraud", there are huge issues in research.
A personal story:
In my early college days trying to do research there would be times I was asked to try to replicate an assay by reading through some published articles and finding whats necessary within the lab I was in (while fumbling through different technologies and chemicals), because I did chemistry and physics. This should be easy for me (?). Following protocols and things not working out, little guidance (maybe a "lets see what (s)he can do" type thing?). But I was trying to do the protocol with what may have been at best truncated or at worst, something that just didn't work. Or maybe I'm just not very good at basic research. Frustrating right?
Now a friend of mine joins a lab, gets put on a few publications just because, "I don't know why, they're putting me on it though..".
If we stop there and submit applications, my friend will automatically be seen as better than me. I am washed, a failure. This doesn't even have to do with the complete fraud that happens, just how terrible the research meritocracy actually is in this country. Publish to publish, put people on the publications who did nothing.
Most of the time research is more about who you know than how good or smart you are.
Another anecdote: I know more MDs that fell into research as residents that got labs than I do MDPhDs that got labs.
Publish or perish sucks… and probably does lead to some bad science.I don't agree with Ricky or Prasad all of the time. But let's talk about this stuff. The rate of non-reproducibility is way too high. Hiding data points can make the difference between a big thumbs up or not. The rates of fraud are way too high, bar none, for everyone. A lot of countries have issues with research, not just the US. Even if it's not just complete "fraud", there are huge issues in research.
A personal story:
In my early college days trying to do research there would be times I was asked to try to replicate an assay by reading through some published articles and finding whats necessary within the lab I was in (while fumbling through different technologies and chemicals), because I did chemistry and physics. This should be easy for me (?). Following protocols and things not working out, little guidance (maybe a "lets see what (s)he can do" type thing?). But I was trying to do the protocol with what may have been at best truncated or at worst, something that just didn't work. Or maybe I'm just not very good at basic research. Frustrating right?
Now a friend of mine joins a lab, gets put on a few publications just because, "I don't know why, they're putting me on it though..".
If we stop there and submit applications, my friend will automatically be seen as better than me. I am washed, a failure. This doesn't even have to do with the complete fraud that happens, just how terrible the research meritocracy actually is in this country. Publish to publish, put people on the publications who did nothing.
Most of the time research is more about who you know than how good or smart you are.
Another anecdote: I know more MDs that fell into research as residents that got labs than I do MDPhDs that got labs.
just how terrible the research meritocracy actually is in this country
Yeah... I already wrote the above screed...you nailed it in one sentence.Id argue the present system seems to be working. Prasads tweet has more to do with fixing human nature than the nih.
I agree...that happenedHear me out on this spitball.
The last time a deep dive was done, at least that I'm aware of, rad onc represented 1.6% of NIH cancer research funding. Doubt it has changed much since then. Deep bench fighting over scraps. And from what I understand the RTB study section is brutal.Hear me out on this spitball. Maybe delete this later:
Do we diminish our field by focusing on research early? By making it such a huge part of our field that it is a year of our training (unneeded, but I digress).
(In competitive years) We force the smartest people who don't want do be researchers (maybe not even radoncs) into gaming the system to try to show they are researchers.
Introducing an overly competitive group into a habitat that requires people to just be super nerdy and love the specific topics.
Ultimately these very smart people end up out competing others because of a competitive nature, not because of true love of the field.
They end up going into the type of career they want to go into, private, community, california, new york, or maybe a few of them take that one science focused job in the middle of America.
We stifle the number of people that would actually provide benefit to the field through sheer interest in the field, by weeding them out from predators looking for a cush over paid field.
tl;dr Ralph was right @medgator
This is only somewhat related, but am I the only one who thinks making USMLE step 1 P/F May end up being a bad thing for people going into competitive fields? I get it, the pressure sucked but at least it put emphasis on something you had to do. Now folks still have to study for it to pass AND engage in something else just to stand out. I suspect that something else will more often than not end up being research they only kinda care about. This feels like a well intended idea that will end up creating more work for a lot of folks in my opinion.Hear me out on this spitball. Maybe delete this later:
Do we diminish our field by focusing on research early? By making it such a huge part of our field that it is a year of our training (unneeded, but I digress).
(In competitive years) We force the smartest people who don't want do be researchers (maybe not even radoncs) into gaming the system to try to show they are researchers.
Introducing an overly competitive group into a habitat that requires people to just be super nerdy and love the specific topics.
Ultimately these very smart people end up out competing others because of a competitive nature, not because of true love of the field.
They end up going into the type of career they want to go into, private, community, california, new york, or maybe a few of them take that one science focused job in the middle of America.
We stifle the number of people that would actually provide benefit to the field through sheer interest in the field, by weeding them out from predators looking for a cush over paid field.
tl;dr Ralph was right @medgator
Love this type of information, would love if someone could do it again over years?The last time a deep dive was done, at least that I'm aware of, rad onc represented 1.6% of NIH cancer research funding. Doubt it has changed much since then. Deep bench fighting over scraps. And from what I understand the RTB study section is brutal.
RTB gets a worse rep than they deserve. All study sections have turn over and they have had some pretty tough groups, but it’s not unique to them. I will say, I had a good friend get a 13th percentile on their last A1 only to have their next submission get triaged. It’s hard to not feel like something is broken when you see that kind of thing happen.The last time a deep dive was done, at least that I'm aware of, rad onc represented 1.6% of NIH cancer research funding. Doubt it has changed much since then. Deep bench fighting over scraps. And from what I understand the RTB study section is brutal.
This is only somewhat related, but am I the only one who thinks making USMLE step 1 P/F May end up being a bad thing for people going into competitive fields? I get it, the pressure sucked but at least it put emphasis on something you had to do. Now folks still have to study for it to pass AND engage in something else just to stand out. I suspect that something else will more often than not end up being research they only kinda care about. This feels like a well intended idea that will end up creating more work for a lot of folks in my opinion.
Nothing I said applies to rad onc anymore. At this point, our something else is limiting your wrap sheet to misdemeanors or not getting caught forging recommendation letters for your application.I do think that, but at this point I don't think there is a reason for it, at least for RadOnc. I am convinced that there are strong forces in some big academic centers and collaborative community docs that want to kill the field. Some of them are here.
The alternative is a field from the 70-90s that no one cared to go into and matched from the bottom of classesHear me out on this spitball. Maybe delete this later:
Do we diminish our field by focusing on research early? By making it such a huge part of our field that it is a year of our training (unneeded, but I digress).
(In competitive years) We force the smartest people who don't want do be researchers (maybe not even radoncs) into gaming the system to try to show they are researchers.
Introducing an overly competitive group into a habitat that requires people to just be super nerdy and love the specific topics.
Ultimately these very smart people end up out competing others because of a competitive nature, not because of true love of the field.
They end up going into the type of career they want to go into, private, community, california, new york, or maybe a few of them take that one science focused job in the middle of America.
We stifle the number of people that would actually provide benefit to the field through sheer interest in the field, by weeding them out from predators looking for a cush over paid field.
tl;dr Ralph was right @medgator
The last time a deep dive was done, at least that I'm aware of, rad onc represented 1.6% of NIH cancer research funding. Doubt it has changed much since then. Deep bench fighting over scraps. And from what I understand the RTB study section is brutal.
This is hardly a deep dive but according to NIH RePORTER, there are currently 4,553 active NCI R01s, of which 147 originated from RTB. This isn't a dollar-for-dollar accounting but this suggests 3% to me.Love this type of information, would love if someone could do it again over years?